Thomas L Sutton
Overview
Explore the profile of Thomas L Sutton including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
71
Citations
336
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sutton T, Patel R, Watson K, Gardner I, Herzig D, Tsikitis V, et al.
Dis Colon Rectum
. 2024 Sep;
68(1):32-40.
PMID: 39264063
Background: Synchronous colorectal liver metastases may be managed with primary-first, simultaneous, or liver-first resection. Relative oncologic outcomes based on treatment sequencing are understudied. Objective: This study aimed to assess oncologic...
2.
Patel R, Salgado-Garza G, Sutton T, Phipps J, Papavasiliou P, Gerry J, et al.
HPB (Oxford)
. 2024 Sep;
26(12):1467-1476.
PMID: 39242329
Background: Pancreatic ductal adenocarcinoma (PDAc) is a lethal malignancy, attributed in part to high rates of rapid recurrence (rrPDAc) following resection. We sought to characterize recurrence rates over time and...
3.
Sutton T, Billingsley K, Johnson A, Corless C, Blanke C, Heinrich M, et al.
J Surg Oncol
. 2024 Jun;
130(1):40-46.
PMID: 38924626
Introduction: Patients with high-risk resected gastrointestinal stromal tumors (GIST) receiving adjuvant imatinib have improved recurrence-free survival (RFS), however whether a complete cytocidal effect exists is unknown. We investigated this using...
4.
Thirasastr P, Sutton T, Joseph C, Lin H, Amini B, Mayo S, et al.
Cancers (Basel)
. 2024 Mar;
16(5).
PMID: 38473266
Ripretinib and avapritinib have demonstrated activity in the late-line treatment of gastrointestinal stomal tumors (GISTs). We investigated whether patients previously treated with ripretinib benefit from avapritinib, and vice versa. Patients...
5.
Finan J, Sutton T, Dixon D, Brody J
Cancer Res
. 2023 Sep;
83(21):3507-3516.
PMID: 37683260
The RNA-binding protein human antigen R (HuR) is a well-established regulator of gene expression at the posttranscriptional level. Its dysregulation has been implicated in various human diseases, particularly cancer. In...
6.
Behrens S, Sutton T, Patel R, Schwantes I, OGrady J, Johnson A, et al.
J Surg Oncol
. 2023 Apr;
128(2):271-279.
PMID: 37095724
Background: Pancreatic adenocarcinoma (PDAC) often impinges on the biliary tree and obstruction necessitates stent placement increasing the risk of surgical site infections (SSIs). We sought to explore the impact of...
7.
Patel R, Parappilly M, Sutton T, Behrens S, Schwantes I, Johnson A, et al.
Am J Surg
. 2023 Apr;
231:55-59.
PMID: 37087362
Background: Pancreatic acinar cell carcinoma (PACC) is a rare exocrine tumor of the pancreas. We evaluated the effect disease stage, surgical intervention, and institutional volume status plays in survival. Methods:...
8.
Patel R, Sutton T, Schwantes I, Behrens S, Pommier R, Rocha F, et al.
J Surg Oncol
. 2023 Mar;
127(6):956-965.
PMID: 36905335
Background And Objectives: Primary resection and debulking of liver metastases have been associated with improved survival in pancreatic neuroendocrine tumors (PNETs). The treatment patterns and outcomes differences between low-volume (LV)...
9.
OConnor A, Shettig A, Santucci N, Sutton T, Bray J, Borzy C, et al.
Am J Surg
. 2023 Mar;
225(5):847-851.
PMID: 36870791
Background: Though telemedicine has been identified as safe and feasible, data on patient reported experiences (PREs) are lacking. We sought to compare PREs between in-person and telemedicine-based perioperative care. Methods:...
10.
Sutton T, Patel R, Behrens S, Schwantes I, Fewel C, Gardiner S, et al.
Am J Surg
. 2023 Mar;
225(5):861-865.
PMID: 36858865
Background: In hormone receptor-positive breast cancer (HRPBC), endocrine therapy is often initiated after adjuvant radiotherapy given concerns of radiation fibrosis. No studies have investigated how this may impact outcomes in...